Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2000
08/10/2000WO2000045830A1 Materials for preventing arteriosclerosis, immunopotentiating materials, vertebrates fed with these materials and eggs thereof
08/10/2000WO2000045824A1 Preventive and therapeutic agents for arteriosclerosis
08/10/2000WO2000045820A1 Use of moxonidine for postmyocardial infarction treatment
08/10/2000WO2000045819A1 Use of cholesterol-lowering agent
08/10/2000WO2000045817A1 Drug combinations comprising (e) -7 - [4 -(4 -fluorophenyl) -6 - isopropyl -2 - [methyl (methylsulfonyl) amino] pyrimidin -5 -yl] (3r,5s) -3,5 - dihydroxyhept -6 - enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
08/10/2000WO2000045811A1 Method for the prevention or reduction of cariovascular events associated with coronary intervention
08/10/2000WO2000045810A1 Method for the prevention or reduction of cardiovascular events associated with coronary intervention
08/10/2000WO2000045809A1 L-arginine based formulations for treating diseases and methods of using same
08/10/2000WO2000045807A1 Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol
08/10/2000WO2000045806A1 α1-ADRENERGIC RECEPTOR ANTAGONISTS
08/10/2000WO2000045795A2 Topical sprays comprising a film forming composition
08/10/2000WO2000045791A2 Method for controlling liposome size
08/10/2000WO2000045634A1 Inositol derivatives for inhibiting superoxide anion production
08/10/2000WO2000027822A3 Tricyclic pyrazole derivatives
08/10/2000WO2000026399A3 Method for the production of quercetin and isoquercetin derivatives
08/10/2000WO2000026239A3 $i(chlamydia) antigens and corresponding dna fragments and uses thereof
08/10/2000WO2000024911A3 Human phospholipases
08/10/2000WO2000021525A3 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
08/10/2000WO2000015206A3 Tryptophanyl ester and their n-acyl derivatives for the prevention and treatment of diseases caused or exacerbated by oxidation processes
08/10/2000WO2000013706A8 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
08/10/2000WO2000013691A9 3-deazaadenosine prevents atherosclerosis and graft vasculopathy
08/10/2000WO2000012118A8 Inhibiting cardiomyocyte death
08/10/2000WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors
08/10/2000DE19906159A1 16-Hydroxyestratriene als selektiv wirksame Estrogene 16-hydroxyestratrienes as selective estrogens effective
08/10/2000DE19904710A1 Substituierte 4-Amino-2-aryl-tetrahydrochinazoline, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical compositions containing them
08/10/2000CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000CA2361615A1 The use of vascular endothelial growth factor 2 antagonist in the treatment of an injury to or disorder of an eye
08/10/2000CA2361581A1 Method for the prevention or reduction of cariovascular events associated with coronary intervention
08/10/2000CA2361578A1 Method for the prevention or reduction of cardiovascular events associated with coronary intervention
08/10/2000CA2361575A1 L-arginine based formulations for treating diseases and methods of using same
08/10/2000CA2361551A1 Method for controlling liposome size
08/10/2000CA2361066A1 Inositol derivatives for inhibiting superoxide anion production
08/10/2000CA2358855A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
08/10/2000CA2358641A1 Use of cholesterol-lowering agent
08/10/2000CA2357013A1 Anti-inflammatory indole derivatives
08/10/2000CA2321107A1 Materials for preventing arteriosclerosis, immunopotentiating materials, vertebrates fed with these materials and eggs thereof
08/09/2000EP1025853A2 Pharmaceutical composition containing S-nitroso-heme proteins and use thereof
08/09/2000EP1025227A2 Human toll homologues
08/09/2000EP1025216A1 Transgenic animal models for cardiac hypertrophy and uses thereof
08/09/2000EP1025116A1 Estra-1,3,5(10)-triene-7alpha-thioethers
08/09/2000EP1025106A2 Allosteric adenosine receptor modulators
08/09/2000EP1025102A1 Bicyclic kinase inhibitors
08/09/2000EP1025100A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
08/09/2000EP1025098A1 Benzothiophenes
08/09/2000EP1025096A1 Substituted chroman derivatives
08/09/2000EP1025095A1 Substituted chroman derivatives
08/09/2000EP1025094A1 Substituted indan derivatives
08/09/2000EP1025090A1 Vitronectin receptor antagonists
08/09/2000EP1025086A1 Benzamidine derivatives as factor xa inhibitors
08/09/2000EP1025082A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
08/09/2000EP1024825A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity
08/09/2000EP1024819A1 Citrus peel extract as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
08/09/2000EP1024813A1 Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
08/09/2000EP1024812A1 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
08/09/2000EP1024811A1 Novel benzodiazepine derivatives as antiarrhythmic agents
08/09/2000EP1024804A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
08/09/2000EP1024801A2 Method for regulating size and growth of vascularized normal tissue
08/09/2000EP1024794A1 Methods of treating capsules and dry, powdered pharmaceutical formulations
08/09/2000EP1024793A1 Osmotic medicament releasing system
08/09/2000EP1024696A1 Combination therapy for reducing the risks associated with cardio- and cerebrovascular disease
08/09/2000EP0820434B1 Phenoxyethylamine derivatives having high affinity for the 5-ht 1a receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives
08/09/2000EP0642513B1 Indolocarbazole imides and their use
08/09/2000CN1262681A 4,5-dihydro-[1H]-benz [g] indazole-3-carboxylic acid derivatives
08/09/2000CN1262676A 吡啶衍生物 Pyridine derivatives
08/09/2000CN1262105A Chinese-medicinal oral liquid for treating cerebral diseases caused by hypertension and its preparing process
08/09/2000CN1055215C 银杏酒及其制备方法 Ginkgo wine and its preparation method
08/09/2000CN1055210C Compound tsaoko injection and preparation method thereof
08/08/2000US6101412 Compositions, apparatus and methods for facilitating surgical procedures
08/08/2000US6100297 Administering antioxidant cardioplegic solution during coronary bypass surgery
08/08/2000US6100282 Thiazole derivatives
08/08/2000US6100272 Tetracyclic spiro compounds as 5HT1B receptor antagonists
08/08/2000US6100271 Compounds which mediate intracellular signaling response to abnormal external stimuli characteristic of diseases; antiinflammatory agents, antifibrotic agents, antisclerotic agents, antitumor agents
08/08/2000US6100268 Vasoconstrictive dihydrobenzopyran derivatives
08/08/2000US6100267 Enzyme inhibitor for treatment of neurodegenerative disorders, strokes, traumatic brain injury, cataracts
08/08/2000US6100266 Hydroxamic and carboxylic acid derivatives
08/08/2000US6100252 Specified compounds including methyl 2-butyl-1-((2'-(2-oxo-3h-1,2,3,5-oxathiadiazol-4-yl)biphenyl) methyl)-benzimidazole-7-carboxylate; use to treat circulatory diseases such as hypertensive diseases and heart diseases
08/08/2000US6100242 Gene therapies for enhancing cardiac function
08/08/2000US6100237 Use of des-Aspartate-angiotensin I as an agent for the treatment and prevention of neointima formation, restenosis, and arteriosclerosis
08/08/2000US6100060 Recombinant expression system of polynucleotide encoding a specific amino acid sequence and present in a host cell; for recombinant production of wnt-5b polypeptides important in developmental signal transduction
08/08/2000US6100037 Polynucleotide encoding a cyclic nucleotide phosphodiesterase having a specific amino acid sequence; diagnosis, treatment, and prevention of cancer and immune disorders; anticarcinogenic/antidiabetic/antiarthritic agents
08/08/2000US6099851 Therapeutic uses of leuprolide acetate
08/08/2000US6099832 Transplants for myocardial scars
08/08/2000US6099823 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/08/2000CA2085796C 3(2h)-pyridazinone derivatives and process for the preparation thereof
08/08/2000CA2018438C Imidazolyl-alkenoic acids
08/08/2000CA2017066C Azaindenes
08/03/2000WO2000045167A2 Non-invasive method for detecting target rna
08/03/2000WO2000044897A1 Method of treating restenosis by antisense targeting of c-myc
08/03/2000WO2000044888A2 Dimethylarginine dimethylaminohydrolases
08/03/2000WO2000044862A1 Process of converting rendered triglyceride oil from marine sources into bland, stable oil
08/03/2000WO2000044763A2 Compositions for treating inflammatory response
08/03/2000WO2000044761A2 Ketolide antibiotics
08/03/2000WO2000044757A1 Hesperitin pro-forms with enhanced bioavailability
08/03/2000WO2000044756A1 Thiazolopyrimidine compounds, process for the preparation of the same and uses thereof
08/03/2000WO2000044755A1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
08/03/2000WO2000044753A1 Pirazino(aza)indole derivatives
08/03/2000WO2000044752A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
08/03/2000WO2000044750A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND Iλ-A$g(a)
08/03/2000WO2000044745A1 Carbamate derivatives of diaryl 1,3,4-oxadiazolone
08/03/2000WO2000044740A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors